Previous 10 | Next 10 |
2024-03-13 14:01:40 ET More on Qiagen, Bio-Techne, etc. Qiagen N.V. 2023 Q4 - Results - Earnings Call Presentation Qiagen N.V. (QGEN) Q4 2023 Earnings Call Transcript Bio-Techne Corporation (TECH) Q2 2024 Earnings Call Transcript Qiagen upgraded at Morgan Sta...
2024-03-12 13:55:37 ET More on Illumina Illumina's Turnaround Play: Betting On NovaSeq X Amidst Rising Competitive Tides Illumina: Stagnant Revenues And Shrinking Margins Amidst Rising Competition Illumina, Inc. (ILMN) Q4 2023 Earnings Call Transcript Corvex ...
2024-03-11 13:07:11 ET More on S&P 500 Index: Japan's Q4 '23 Contraction Revised Away, Helping Keep Yen Bid S&P 500: 'Everything' Is Overbought, Not Just Semis And Nvidia S&P 500: A Significant Change - Week Starting 11th March (Technical Analysis) ...
2024-03-10 13:00:53 ET More on the markets S&P 500: Time To Hedge, Here's How How The S&P 500 Could Actually Be Closer To 4,200 Than 5,000 SPDR S&P 500 ETF And Invesco QQQ Trust: Almost All Investors Are Crowded Into The Same Side Of The Boat Cata...
Illumina scientists tailor-made research solutions for detecting genes in difficult-to-read regions that cause both common and rare diseases Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / March 8, 2024 / When scientists want to sequence a DNA sample on an Il...
NORTHAMPTON, MA / ACCESSWIRE / March 7, 2024 / Illumina WorldFish and the Earlham Institute are using genomics to improve tilapia for the sake of global food sustainability Originally published on Illumina News Center The United Nations projects that the total human population will ex...
2024-02-28 04:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-26 18:29:00 ET Gene-sequencing stock Illumina (NASDAQ: ILMN) was a standout in the biotech sector Monday, with its share-price rise convincingly beating the S&P 500 index. Investors were cheered by a stock buy made by a high-profile insider. As a result, its shares c...
2024-02-23 04:50:00 ET Summary Polen Capital is a high-conviction growth investment manager. We scour the globe in search of the highest quality, sustainable companies to invest in. The Polen Focus Growth Composite Portfolio (the “Portfolio”) outpaced the Russell 100...
2024-02-23 03:42:37 ET Summary Illumina's stock declined 19% post "Sell" recommendation; S&P 500 rose 10%, highlighting concerns over GRAIL acquisition legal risks. 2023 revenue fell to $4,504 million from $4,584 million, with gross margins dropping from 69.6% in 2021 to 60.9%...
News, Short Squeeze, Breakout and More Instantly...
Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL PR Newswire GRAIL to host Capital Markets Day on May 13 , 2024 SAN DIEGO , May 6, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that it h...
2024-05-03 15:30:03 ET Stephens analyst issues NEUTRAL recommendation for ILMN on May 3, 2024 01:00PM ET. The previous analyst recommendation was Neutral. ILMN was trading at $119.71 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current...